(Q41808544)

12 October 2017

Effect of oral naltrexone on pruritus in cholestatic patients (English)

1 reference

12 October 2017

0 references

Fariborz Mansour-Ghanaei

1

1 reference

12 October 2017

Amir Taheri

2

1 reference

12 October 2017

Hossein Froutan

3

1 reference

12 October 2017

Hadi Ghofrani

4

1 reference

12 October 2017

Mohsen Nasiri-Toosi

5

1 reference

12 October 2017

Amir-Hossein Bagherzadeh

6

1 reference

12 October 2017

Mohammad-Jafar Farahvash

7

1 reference

12 October 2017

Shahram Mirmomen

8

1 reference

12 October 2017

Naser Ebrahimi-Dariani

9

1 reference

12 October 2017

Elham Farhangi

10

1 reference

12 October 2017

Zahra Pourrasouli

11

1 reference

12 October 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

World Journal of Gastroenterology

12 October 2017

1 reference

12 October 2017

12

1 reference

12 October 2017

7

1 reference

12 October 2017

1125-1128

1 reference

Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients

12 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Assessing the efficacy of medical treatments for alcohol use disorders

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

The pathogenesis and treatment of pruritus and fatigue in patients with PBC.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

The pruritus of cholestasis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Opioid antagonists in the treatment of pruritus from cholestatic liver disease

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Plasma from patients with the pruritus of cholestasis induces opioid receptor-mediated scratching in monkeys

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Pruritus associated with cholestasis. A review of pathogenesis and management

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Serum bile acids in primary biliary cirrhosis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Role of plasmapheresis in primary biliary cirrhosis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Opioid peptides and primary biliary cirrhosis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Clinical applications of visual analogue scales: a critical review.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Plasma leucine enkephalin is increased in liver disease

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Rifampin relieves pruritus in children with cholestatic liver disease

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

The pruritus of cholestasis: from bile acids to opiate agonists

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Treatment of pruritus of primary biliary cirrhosis with rifampin

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Management of the pruritus of cholestasis: potential role of opiate antagonists

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

A controlled trial of naloxone infusions for the pruritus of chronic cholestasis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Effects of long-term rifampicin administration in primary biliary cirrhosis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

The pruritus of cholestasis and the opioid system

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and topruritus

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

A controlled trial of ondansetron in the pruritus of cholestasis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Acute opioid withdrawal on accidental injection of naltrexone

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Delayed opioid withdrawal-like reaction in primary biliary cirrhosis following naloxone therapy.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

[Limited role of naltrexone in the treatment of opiate addiction]

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Naltrexone and relapse prevention treatment for cocaine-dependent patients

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Lack of hepatotoxicity with naltrexone treatment

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087908

Effect of liver cirrhosis on the systemic availability of naltrexone in humans

18 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.3748%2FWJG.V12.I7.1125

Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study

21 January 2018

1 reference

12 December 2020

Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines

1 reference

12 December 2020

Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study

1 reference

12 December 2020

Pain as a complication of use of opiate antagonists for symptom control in cholestasis

1 reference

12 December 2020

Naltrexone and hepatotoxicity

1 reference

12 December 2020

Efficacy of liver transplantation in patients with primary biliary cirrhosis

1 reference

12 December 2020

Open-label trial of oral nalmefene therapy for the pruritus of cholestasis

1 reference

12 December 2020

Hepatoprotective properties of ursodeoxycholic acid

1 reference

12 December 2020

The pruritus of cholestasis

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V12.I7.1125

1 reference

12 October 2017

1 reference

12 October 2017

PubMed publication ID

16534857

1 reference